You searched for "innovation"
What's trending Jun/Jul 2023
5 June 2023
| Liam YN Wong
|
EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #whoopigoldberg #presbyopia #bionic Whoopi Goldberg made a name for herself in blockbusters such as the Oscar-winning Ghost and Sister Act. She...
Brave new world
3 June 2024
| Peter Cackett, David Lockington
It’s a great honour to be handed the editorial relay baton by Professor Bal Dhillon and I hope I don’t fumble it along the way. As I put pen to paper, I reflect on Bal’s signing off in the last...
Designing ophthalmology services Part 3: How do we address the queues post‑COVID-19?
5 August 2020
| Martin Dowdal, Caspar Gibbon, Kate Silvester
|
EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
Part 1 of this series available herePart 2 of this series available here There is going to be enormous demand on ophthalmology services as they start to welcome patients back. The authors explain how modelling can help make the most...
RPE tears after intravitreal Lucentis
1 February 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...
5-FU vs. Avastin as adjunct to conjunctival autograft
The authors compare the outcome of pterygium treatment using 5-fluorouracil as an adjunct to free conjunctival autograft versus bevacizumab (Avastin) as an adjunct to free conjunctival autograft, via a randomised controlled prospective study. Seventy eyes of 70 patients were included...Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...The disease burden of AMD
1 December 2015
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
In this multi-centre, prospective, observational, time and motion study the authors assessed the time burden of managing wet AMD for doctors, staff, patients and caregivers in the USA. The study spanned the period from March 2011 to August 2012, and...
How does cataract surgery affect eyes with wet AMD?
In this retrospective cohort study the authors’ primary objective was to assess whether cataract surgery in eyes with wet age-related macular degeneration (AMD), triggered its progression. The surgical group comprised of 40 eyes versus 42 eyes in the non-surgical control...Clinical evaluation of a multifocal aspheric diffractive intraocular lens
1 February 2014
| Jonathan Chan
|
EYE - Cataract, EYE - Refractive
|
Lens and zonules, Optics and Refraction, Treatment Surgery
This is a multi-centre prospective study involving five different centres in Europe including 52 patients with cataract. The average age was 68.5±10.5 years, 35 females were bilateral implanted with aspheric diffractive multifocal lens implantation of the Tecnis 1-Piece multifocal intraocular...
DRIL after macular oedema treatment in BRVO
1 June 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors report the analysis of a single-site, retrospective, cross-sectional study to evaluate the association between disorganisation of the retinal inner layers (DRIL) and visual acuity (VA) after anti-VEGF treatment for macular oedema (MO) due to branch retinal vein occlusion...
Insights in resistant diabetic macular oedema
5 August 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
The challenges of rural optometry and how independent prescribing has helped
1 February 2017
| Ian Rough
|
EYE - General
Why move from a busy professional independent Aberdeen optometry practice over 200 miles to one of the most remote places in the United Kingdom? I could talk about the professional challenge of supporting a rural community, or the chance to...